ten Haaft PJ - Search Results

1

Infectivity and virulence of cell-associated SIVmac after single passage in vivo.

Niphuis H, Dubbes RH, ten Haaft PJ, Koornstra WH, Bontrop RE, Cranage MP, Heeney JL. Niphuis H, et al. Among authors: ten haaft pj. AIDS. 1994 Dec;8(12):1730-1. doi: 10.1097/00002030-199412000-00016. AIDS. 1994. PMID: 7888125 No abstract available.

2

Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.

Bogers WM, Niphuis H, ten Haaft P, Laman JD, Koornstra W, Heeney JL. Bogers WM, et al. AIDS. 1995 Dec;9(12):F13-8. AIDS. 1995. PMID: 8605046

3

Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees.

ten Haaft P, Murthy K, Salas M, McClure H, Dubbes R, Koornstra W, Niphuis H, Davis D, van der Groen G, Heeney J. ten Haaft P, et al. AIDS. 2001 Nov 9;15(16):2085-92. doi: 10.1097/00002030-200111090-00003. AIDS. 2001. PMID: 11684927

4

A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection.

Bogers WM, Bergmeier LA, Ma J, Oostermeijer H, Wang Y, Kelly CG, Ten Haaft P, Singh M, Heeney JL, Lehner T. Bogers WM, et al. AIDS. 2004 Jan 2;18(1):25-36. doi: 10.1097/00002030-200401020-00003. AIDS. 2004. PMID: 15090826

5

A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection.

Mooij P, van der Kolk M, Bogers WM, ten Haaft PJ, Van Der Meide P, Almond N, Stott J, Deschamps M, Labbe D, Momin P, Voss G, Von Hoegen P, Bruck C, Heeney JL. Mooij P, et al. Among authors: ten haaft pj. AIDS. 1998 Mar 26;12(5):F15-22. doi: 10.1097/00002030-199805000-00002. AIDS. 1998. PMID: 9543435

6

Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.

Heeney JL, de Vries P, Dubbes R, Koornstra W, Niphuis H, ten Haaft P, Boes J, Dings ME, Morein B, Osterhaus AD. Heeney JL, et al. J Med Primatol. 1992 Feb-May;21(2-3):126-30. J Med Primatol. 1992. PMID: 1433263

7

Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge.

Heeney JL, Holterman L, ten Haaft P, Dubbes R, Koornstra W, Teeuwsen V, Bourquin P, Norley S, Niphuis H. Heeney JL, et al. AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S117-21. AIDS Res Hum Retroviruses. 1994. PMID: 7865285

8

Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.

Heeney JL, van Els C, de Vries P, ten Haaft P, Otting N, Koornstra W, Boes J, Dubbes R, Niphuis H, Dings M, Cranage M, Norley S, Jonker M, Bontrop RE, Osterhaus A. Heeney JL, et al. J Exp Med. 1994 Aug 1;180(2):769-74. doi: 10.1084/jem.180.2.769. J Exp Med. 1994. PMID: 8046353 Free PMC article.

9

Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta.

Bogers WM, Dubbes R, ten Haaft P, Niphuis H, Cheng-Mayer C, Stahl-Hennig C, Hunsmann G, Kuwata T, Hayami M, Jones S, Ranjbar S, Almond N, Stott J, Rosenwirth B, Heeney JL. Bogers WM, et al. Virology. 1997 Sep 15;236(1):110-7. doi: 10.1006/viro.1997.8744. Virology. 1997. PMID: 9299623 Free article.

10

The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques.

Holterman L, Niphuis H, Koornstra W, Dubbes R, ten Haaft P, Heeney JL. Holterman L, et al. J Gen Virol. 2000 Jul;81(Pt 7):1719-26. doi: 10.1099/0022-1317-81-7-1719. J Gen Virol. 2000. PMID: 10859377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters